We are live on ! Find out more
GL

GLG LLC Portfolio holdings

AUM $1.39B
1-Year Est. Return 24.01%
This Fund
S&P 500
This Quarter Est. Return
+4.12%
1 Year Est. Return
+24.01%
3 Year Est. Return
+43.2%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.45B
AUM Growth
+$46.3M
Cap. Flow
-$28.4M
Cap. Flow %
-1.96%
Top 10 Hldgs %
17.68%
Holding
579
New
74
Increased
328
Reduced
94
Closed
69

Top Buys

Rank Stock Value
1
AMPY icon
Amplify Energy
AMPY
+$22.5M
2
AAPL icon
Apple
AAPL
+$12.6M
3
JNJ icon
Johnson & Johnson
JNJ
+$12M
4
GWR
Genesee & Wyoming Inc.
GWR
+$10.7M
5
BAS
Basis Energy Services, Inc.
BAS
+$9.5M

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$9.43M
2
NSC icon
Norfolk Southern
NSC
+$9.25M
3
META icon
Meta Platforms (Facebook)
META
+$8.95M
4
JPM icon
JPMorgan Chase
JPM
+$8.9M
5
AMZN icon
Amazon
AMZN
+$8.39M

Sector Composition

Rank Sector Weight
1 Financials 11.86%
2 Technology 10.95%
3 Healthcare 10.44%
4 Energy 10.18%
5 Industrials 9.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LRCX icon
526
Lam Research
LRCX
$384B
– –
-90,540
Closed -$858K
NFLX icon
527
CALL
Netflix
NFLX
$285B
– –
-808,000
Closed -$7.96M
NTB icon
528
Bank of N.T. Butterfield & Son
NTB
$2.41B
– –
-65,351
Closed -$1.62M
NVDA icon
529
NVIDIA
NVDA
$4.92T
– –
-2,470,000
Closed -$5.16M
QCOM icon
530
CALL
Qualcomm
QCOM
$180B
– –
-400,000
Closed -$27.4M
QCOM icon
531
Qualcomm
QCOM
$180B
– –
-76,800
Closed -$5.26M
QRVO icon
532
Qorvo
QRVO
$7.56B
– –
-8,319
Closed -$464K
REGN icon
533
Regeneron Pharmaceuticals
REGN
$70.5B
– –
-4,180
Closed -$1.68M
RIG icon
534
Transocean
RIG
$5.56B
– –
-200,000
Closed -$2.13M
RIO icon
535
Rio Tinto
RIO
$145B
– –
-59,774
Closed -$2M
SHW icon
536
Sherwin-Williams
SHW
$79.8B
– –
-13,074
Closed -$1.21M
SMG icon
537
CALL
ScottsMiracle-Gro
SMG
$4.03B
– –
-175,000
Closed -$14.6M
SPY icon
538
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$781B
– –
-86,500
Closed -$18.7M
SYK icon
539
Stryker
SYK
$122B
– –
-13,561
Closed -$1.58M
SYNA icon
540
Synaptics
SYNA
$4.44B
– –
-35,440
Closed -$2.08M
TEVA icon
541
Teva Pharmaceuticals
TEVA
$36.1B
– –
-205,000
Closed -$9.43M
TFC icon
542
Truist Financial
TFC
$62.3B
– –
-42,600
Closed -$1.61M
TSLA icon
543
Tesla
TSLA
$1.39T
– –
-66,525
Closed -$874K
TTWO icon
544
Take-Two Interactive
TTWO
$44.4B
– –
-30,000
Closed -$1.35M
VVV icon
545
Valvoline
VVV
$5.04B
– –
-259,000
Closed -$6.08M
PDCE
546
DELISTED
PDC Energy, Inc.
PDCE
– –
-66,878
Closed -$4.49M
CLVS
547
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-123,300
Closed -$4.45M
CLVS
548
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-20,000
Closed -$721K
TWTR
549
DELISTED
Twitter, Inc.
TWTR
– –
-28,960
Closed -$668K
ENDP
550
CALL
DELISTED
Endo International plc
ENDP
– –
-234,000
Closed -$4.71M
19 20 21
22
23

Similar funds

IH
IFC Holdings Tampa, Florida $1.45B AUM 15.5% 1-Year Est. Return
TAM
TPH Asset Management Houston, Texas $1.01B AUM 2.14% 1-Year Est. Return
SI
SII Investments Appleton, Wisconsin $965M AUM 15.44% 1-Year Est. Return
GES
GO ETF Solutions London, United Kingdom $689M AUM 29.59% 1-Year Est. Return
AS
Acorns Securities Irvine, California $660M AUM
GP
GLG Partners London, United Kingdom $2.14B AUM 21.14% 1-Year Est. Return
QAM
Quentec Asset Management New York $634M AUM 22.87% 1-Year Est. Return
BTIS
BB&T Investment Services Charlotte, North Carolina $595M AUM 15.91% 1-Year Est. Return

GLG LLC's Q4 2016 Portfolio in Review

As of Q4 2016, GLG LLC held 579 positions worth $1.45B, up 3.3% from $1.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

GLG LLC's Q4 2016 filing shows 74 new, 328 increased, 94 reduced and 69 closed positions. Its largest new stake was Amplify Energy: 1,136,144 shares worth $23.6M. The largest sale was Teva Pharmaceuticals, an estimated $9.43M.

By sector, the portfolio is most concentrated in Financials at 12% of assets, up from 11% a quarter earlier, followed by Technology and Healthcare.

  • GLG LLC's largest Q4 2016 buy was Amplify Energy: 1,136,144 shares worth $23.6M.
  • GLG LLC added most to Apple in Q4 2016, an estimated $12.6M increase.
  • GLG LLC's biggest Q4 2016 reduction was Norfolk Southern, cutting an estimated $9.25M.
  • GLG LLC fully exited Teva Pharmaceuticals in Q4 2016, selling an estimated $9.43M.
  • GLG LLC's ten largest holdings make up 18% of its $1.45B portfolio in Q4 2016.
  • GLG LLC opened 74 new positions and closed 69 in Q4 2016.
  • GLG LLC's portfolio value rose 3.3% quarter-over-quarter to $1.45B.

Based on GLG LLC's 13F filing for Q4 2016, filed 14 Feb 2017.